Listing 1 - 4 of 4 |
Sort by
|
Choose an application
Les changements radicaux qui affectèrent le monde de l'art au cours des années 1789-1848 ont transformé en profondeur notre rapport aux œuvres. Ce recueil étudie les conséquences, hors des frontières françaises, des guerres et des bouleversements sociopolitiques générés par la Révolution sur les orientations du goût, les pratiques du collectionnisme, la question des identités culturelles et nationales, ainsi que sur la création de nouvelles institutions artistiques à travers l'Europe et les Amériques.
Franse revolutie --- Art --- nationalism --- art market --- History of France --- collecting --- Louis Philippe [Duke of Orléans] --- anno 1700-1799 --- anno 1800-1899 --- Art appreciation --- Marketing --- History --- Collectors and collecting --- Commercialisation --- Histoire --- Collectionneurs et collections --- Appréciation --- France --- Art and the revolution --- Influence --- Art et révolution --- kunsthandel --- geschiedenis --- Franse Revolutie --- verzameling duc d'Orléans --- Ancien Régime --- Rubens, Peter Paul --- Filips II (Hertog van Orléans) --- 1789 - 1848 --- 18de eeuw --- 19de eeuw --- Frankrijk --- Europa --- Amerika --- Brazilië --- History of art --- 18th-19th centuries --- Revolutions --- Orléans, Maison d' --- Revolutions. --- Appréciation --- Art et révolution --- History. --- Art and the revolution. --- kunsthandel. --- geschiedenis. --- Franse Revolutie. --- verzameling duc d'Orléans. --- Ancien Régime. --- Rubens, Peter Paul. --- Filips II (Hertog van Orléans). --- 1789 - 1848. --- 18de eeuw. --- 19de eeuw. --- Frankrijk. --- Europa. --- Amerika. --- Brazilië. --- 18e sièccle --- 19e siècle
Choose an application
Cancer is a leading cause of death worldwide, claiming millions of lives each year. Cancer biology is an essential research field to understand how cancer develops, evolves, and responds to therapy. By taking advantage of a series of “omics” technologies (e.g., genomics, transcriptomics, and epigenomics), computational methods in bioinformatics and machine learning can help scientists and researchers to decipher the complexity of cancer heterogeneity, tumorigenesis, and anticancer drug discovery. Particularly, bioinformatics enables the systematic interrogation and analysis of cancer from various perspectives, including genetics, epigenetics, signaling networks, cellular behavior, clinical manifestation, and epidemiology. Moreover, thanks to the influx of next-generation sequencing (NGS) data in the postgenomic era and multiple landmark cancer-focused projects, such as The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC), machine learning has a uniquely advantageous role in boosting data-driven cancer research and unraveling novel methods for the prognosis, prediction, and treatment of cancer.
Research & information: general --- Biology, life sciences --- tumor mutational burden --- DNA damage repair genes --- immunotherapy --- biomarker --- biomedical informatics --- breast cancer --- estrogen receptor alpha --- persistent organic pollutants --- drug-drug interaction networks --- molecular docking --- NGS --- ctDNA --- VAF --- liquid biopsy --- filtering --- variant calling --- DEGs --- diagnosis --- ovarian cancer --- PUS7 --- RMGs --- CPA4 --- bladder urothelial carcinoma --- immune cells --- T cell exhaustion --- checkpoint --- architectural distortion --- image processing --- depth-wise convolutional neural network --- mammography --- bladder cancer --- Annexin family --- survival analysis --- prognostic signature --- therapeutic target --- R Shiny application --- RNA-seq --- proteomics --- multi-omics analysis --- T-cell acute lymphoblastic leukemia --- CCLE --- sitagliptin --- thyroid cancer (THCA) --- papillary thyroid cancer (PTCa) --- thyroidectomy --- metastasis --- drug resistance --- n/a --- biomarker identification --- transcriptomics --- machine learning --- prediction --- variable selection --- major histocompatibility complex --- bidirectional long short-term memory neural network --- deep learning --- cancer --- incidence --- mortality --- modeling --- forecasting --- Google Trends --- Romania --- ARIMA --- TBATS --- NNAR
Choose an application
Cancer is a leading cause of death worldwide, claiming millions of lives each year. Cancer biology is an essential research field to understand how cancer develops, evolves, and responds to therapy. By taking advantage of a series of “omics” technologies (e.g., genomics, transcriptomics, and epigenomics), computational methods in bioinformatics and machine learning can help scientists and researchers to decipher the complexity of cancer heterogeneity, tumorigenesis, and anticancer drug discovery. Particularly, bioinformatics enables the systematic interrogation and analysis of cancer from various perspectives, including genetics, epigenetics, signaling networks, cellular behavior, clinical manifestation, and epidemiology. Moreover, thanks to the influx of next-generation sequencing (NGS) data in the postgenomic era and multiple landmark cancer-focused projects, such as The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC), machine learning has a uniquely advantageous role in boosting data-driven cancer research and unraveling novel methods for the prognosis, prediction, and treatment of cancer.
tumor mutational burden --- DNA damage repair genes --- immunotherapy --- biomarker --- biomedical informatics --- breast cancer --- estrogen receptor alpha --- persistent organic pollutants --- drug-drug interaction networks --- molecular docking --- NGS --- ctDNA --- VAF --- liquid biopsy --- filtering --- variant calling --- DEGs --- diagnosis --- ovarian cancer --- PUS7 --- RMGs --- CPA4 --- bladder urothelial carcinoma --- immune cells --- T cell exhaustion --- checkpoint --- architectural distortion --- image processing --- depth-wise convolutional neural network --- mammography --- bladder cancer --- Annexin family --- survival analysis --- prognostic signature --- therapeutic target --- R Shiny application --- RNA-seq --- proteomics --- multi-omics analysis --- T-cell acute lymphoblastic leukemia --- CCLE --- sitagliptin --- thyroid cancer (THCA) --- papillary thyroid cancer (PTCa) --- thyroidectomy --- metastasis --- drug resistance --- n/a --- biomarker identification --- transcriptomics --- machine learning --- prediction --- variable selection --- major histocompatibility complex --- bidirectional long short-term memory neural network --- deep learning --- cancer --- incidence --- mortality --- modeling --- forecasting --- Google Trends --- Romania --- ARIMA --- TBATS --- NNAR
Choose an application
Cancer is a leading cause of death worldwide, claiming millions of lives each year. Cancer biology is an essential research field to understand how cancer develops, evolves, and responds to therapy. By taking advantage of a series of “omics” technologies (e.g., genomics, transcriptomics, and epigenomics), computational methods in bioinformatics and machine learning can help scientists and researchers to decipher the complexity of cancer heterogeneity, tumorigenesis, and anticancer drug discovery. Particularly, bioinformatics enables the systematic interrogation and analysis of cancer from various perspectives, including genetics, epigenetics, signaling networks, cellular behavior, clinical manifestation, and epidemiology. Moreover, thanks to the influx of next-generation sequencing (NGS) data in the postgenomic era and multiple landmark cancer-focused projects, such as The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC), machine learning has a uniquely advantageous role in boosting data-driven cancer research and unraveling novel methods for the prognosis, prediction, and treatment of cancer.
Research & information: general --- Biology, life sciences --- tumor mutational burden --- DNA damage repair genes --- immunotherapy --- biomarker --- biomedical informatics --- breast cancer --- estrogen receptor alpha --- persistent organic pollutants --- drug-drug interaction networks --- molecular docking --- NGS --- ctDNA --- VAF --- liquid biopsy --- filtering --- variant calling --- DEGs --- diagnosis --- ovarian cancer --- PUS7 --- RMGs --- CPA4 --- bladder urothelial carcinoma --- immune cells --- T cell exhaustion --- checkpoint --- architectural distortion --- image processing --- depth-wise convolutional neural network --- mammography --- bladder cancer --- Annexin family --- survival analysis --- prognostic signature --- therapeutic target --- R Shiny application --- RNA-seq --- proteomics --- multi-omics analysis --- T-cell acute lymphoblastic leukemia --- CCLE --- sitagliptin --- thyroid cancer (THCA) --- papillary thyroid cancer (PTCa) --- thyroidectomy --- metastasis --- drug resistance --- biomarker identification --- transcriptomics --- machine learning --- prediction --- variable selection --- major histocompatibility complex --- bidirectional long short-term memory neural network --- deep learning --- cancer --- incidence --- mortality --- modeling --- forecasting --- Google Trends --- Romania --- ARIMA --- TBATS --- NNAR --- tumor mutational burden --- DNA damage repair genes --- immunotherapy --- biomarker --- biomedical informatics --- breast cancer --- estrogen receptor alpha --- persistent organic pollutants --- drug-drug interaction networks --- molecular docking --- NGS --- ctDNA --- VAF --- liquid biopsy --- filtering --- variant calling --- DEGs --- diagnosis --- ovarian cancer --- PUS7 --- RMGs --- CPA4 --- bladder urothelial carcinoma --- immune cells --- T cell exhaustion --- checkpoint --- architectural distortion --- image processing --- depth-wise convolutional neural network --- mammography --- bladder cancer --- Annexin family --- survival analysis --- prognostic signature --- therapeutic target --- R Shiny application --- RNA-seq --- proteomics --- multi-omics analysis --- T-cell acute lymphoblastic leukemia --- CCLE --- sitagliptin --- thyroid cancer (THCA) --- papillary thyroid cancer (PTCa) --- thyroidectomy --- metastasis --- drug resistance --- biomarker identification --- transcriptomics --- machine learning --- prediction --- variable selection --- major histocompatibility complex --- bidirectional long short-term memory neural network --- deep learning --- cancer --- incidence --- mortality --- modeling --- forecasting --- Google Trends --- Romania --- ARIMA --- TBATS --- NNAR
Listing 1 - 4 of 4 |
Sort by
|